Cargando…

Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality

Objectives: To analyze the current situation of cross-border access to clinical trials in the EU with an overview of stakeholders' real-life experience, and to identify the needs, challenges, and potential for facilitation of cross-border access. Methods: We employed a mixed methods design. Sem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lalova, Teodora, Padeanu, Cristina, Negrouk, Anastassia, Lacombe, Denis, Geissler, Jan, Klingmann, Ingrid, Huys, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642582/ https://www.ncbi.nlm.nih.gov/pubmed/33195343 http://dx.doi.org/10.3389/fmed.2020.585722

Ejemplares similares

Rethinking informed consent in the time of COVID-19: An exploratory survey
por: De Sutter, Evelien, et al.
Publicado: (2022)

Challenges related to data protection in clinical research before and during the COVID-19 pandemic: An exploratory study
por: Lalova-Spinks, Teodora, et al.
Publicado: (2022)

Making Change Happen in Health
por: Horgan, Denis, et al.
Publicado: (2017)

The application of data altruism in clinical research through empirical and legal analysis lenses
por: Lalova-Spinks, Teodora, et al.
Publicado: (2023)

International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective
por: Shash, Emad, et al.
Publicado: (2013)

International Rare Cancers Initiative (IRCI)
por: Keat, Nicola, et al.
Publicado: (2013)

Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
por: Stahel, Rolf A, et al.
Publicado: (2020)

Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients
por: Negrouk, Anastassia, et al.
Publicado: (2017)

The effect of border closure on road potential accessibility in the regions of the EU-27. The case of the COVID-19 pandemic
por: Rosik, Piotr, et al.
Publicado: (2022)

How to balance valuable innovation with affordable access to medicines in Belgium?
por: Simoens, Steven, et al.
Publicado: (2022)

Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology
por: Broes, Stefanie, et al.
Publicado: (2018)

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
por: Broes, Stefanie, et al.
Publicado: (2020)

Does Europe Need an EU Product Safety Directive for Access Scaffolding?
por: Rubio-Romero, Juan Carlos, et al.
Publicado: (2019)

Serious Alert and Border Rejection Notifications on Food in the EU RASFF
por: Papapanagiotou, Elias P.
Publicado: (2021)

Human security at the Mediterranean borders: humanitarian discourse in the EU periphery
por: Panebianco, Stefania
Publicado: (2021)

Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective
por: Broes, Stefanie, et al.
Publicado: (2020)

Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
por: Saesen, Robbe, et al.
Publicado: (2020)

How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer
por: Saesen, Robbe, et al.
Publicado: (2022)

Crimmigration checks in the internal border areas of the EU: Finding the discretion that matters
por: van der Woude, Maartje, et al.
Publicado: (2017)

Potential effects of the EU’s carbon border adjustment mechanism on the Turkish economy
por: Acar, Sevil, et al.
Publicado: (2021)

Cross-Border Quest: The Reality and Legality of Transplant Tourism
por: Ambagtsheer, Frederike, et al.
Publicado: (2012)

A coordinated EU approach to informed access decisions: CAVOD process proposals – the possibility to turn concept into reality?
por: Hughes-Wilson, Wills
Publicado: (2012)

Attending to cross-border sociocultural competence in bilingual programs in the Polish-Czech border region: An exploratory study
por: Hopkins, Megan, et al.
Publicado: (2023)

Innovative Approaches to Increase Access to Medicines in Developing Countries
por: Stevens, Hilde, et al.
Publicado: (2017)

Issues arising when crossing a border to give birth: an exploratory study on the French-Belgian border
por: Kiasuwa Mbengi, R.L., et al.
Publicado: (2014)

Detection and Characterization of Staphylococcus aureus and Methicillin-Resistant S. aureus in Foods Confiscated in EU Borders
por: Rodríguez-Lázaro, David, et al.
Publicado: (2017)

Adapting the EU Economic Governance to New Macroeconomic and Political Realities
por: Fargnoli, Raffaele
Publicado: (2020)

Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium
por: Pirnay, Jean-Paul, et al.
Publicado: (2015)

Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments
por: Saesen, Robbe, et al.
Publicado: (2023)

A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population
por: Wargenau, Manfred, et al.
Publicado: (2022)

Mycobacterium tuberculosis Population in Northwestern Russia: An Update from Russian-EU/Latvian Border Region
por: Mokrousov, Igor, et al.
Publicado: (2012)

EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management
por: Van Bortel, Luc, et al.
Publicado: (2018)

Accelerating Patients’ Access to Advanced Therapies in the EU
por: Elsanhoury, Ahmed, et al.
Publicado: (2017)

Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study
por: De Weerdt, Elfi, et al.
Publicado: (2017)

Exploratory Application of Augmented Reality/Mixed Reality Devices for Acute Care Procedure Training
por: Kobayashi, Leo, et al.
Publicado: (2018)

Oversight of EU medical data transfers – an administrative law perspective on cross-border biomedical research administration
por: Reichel, Jane
Publicado: (2017)

Using Open, Public Data for Security Provision: Ethical Perspectives on Risk-Based Border Checks in the EU
por: Weydner-Volkmann, Sebastian
Publicado: (2023)

Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
por: Pauwels, Kim, et al.
Publicado: (2016)

Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel
por: Kanters, Tim A., et al.
Publicado: (2017)

How prepared are we for cross-border outbreaks? An exploratory analysis of cross-border response networks for outbreaks of multidrug resistant microorganisms in the Netherlands and Germany
por: Maessen, Jacklien H. J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mpvo18joi6s4njo4at4mjov297